Laurence W. Lytton 13D and 13G filings for scPharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:58 pm Purchase | 2024-09-30 | 13G | scPharmaceuticals Inc. SCPH | Laurence W. Lytton | 2,944,932 5.900% | 1,119,698 (+61.35%) | Filing |
| 2024-04-29 2:34 pm Purchase | 2024-04-17 | 13G | scPharmaceuticals Inc. SCPH | Laurence W. Lytton | 1,825,234 5.100% | 1,825,234 (New Position) | Filing |